306 related articles for article (PubMed ID: 8635652)
21. Genetically determined differences in newborn rat islet sensitivity to interleukin-1 in vitro: no association with the diabetes prone phenotype in the BB-rat.
Andersen HU; Mandrup-Poulsen T; Egeberg J; Helqvist S; Nerup J
Acta Endocrinol (Copenh); 1989 Jan; 120(1):92-8. PubMed ID: 2643251
[TBL] [Abstract][Full Text] [Related]
22. Prolonged STAT1 activation is associated with interferon-gamma priming for interleukin-1-induced inducible nitric-oxide synthase expression by islets of Langerhans.
Heitmeier MR; Scarim AL; Corbett JA
J Biol Chem; 1999 Oct; 274(41):29266-73. PubMed ID: 10506184
[TBL] [Abstract][Full Text] [Related]
23. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
24. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats.
Singh A; Sventek P; Larivière R; Thibault G; Schiffrin EL
Am J Hypertens; 1996 Sep; 9(9):867-77. PubMed ID: 8879343
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets.
Welsh N; Sandler S
Biochem Biophys Res Commun; 1992 Jan; 182(1):333-40. PubMed ID: 1731791
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
[TBL] [Abstract][Full Text] [Related]
27. IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide.
Weksler-Zangen S; Aharon-Hananel G; Mantzur C; Aouizerat T; Gurgul-Convey E; Raz I; Saada A
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E648-57. PubMed ID: 24425765
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
[TBL] [Abstract][Full Text] [Related]
29. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes.
Arnush M; Scarim AL; Heitmeier MR; Kelly CB; Corbett JA
J Immunol; 1998 Mar; 160(6):2684-91. PubMed ID: 9510167
[TBL] [Abstract][Full Text] [Related]
30. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
Andersson AK; Flodström M; Sandler S
Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
[TBL] [Abstract][Full Text] [Related]
31. Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets.
Bleich D; Chen S; Bursten SL; Nadler JL
Endocrinology; 1996 Nov; 137(11):4871-7. PubMed ID: 8895359
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans.
Corbett JA; Kwon G; Misko TP; Rodi CP; McDaniel ML
Am J Physiol; 1994 Jul; 267(1 Pt 1):C48-54. PubMed ID: 7519400
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production.
Flodström M; Eizirik DL
Endocrinology; 1997 Jul; 138(7):2747-53. PubMed ID: 9202213
[TBL] [Abstract][Full Text] [Related]
34. Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitric oxide synthase in rat pancreatic islets.
Salehi A; Ekelund M; Henningsson R; Lundquist I
Endocrine; 2001 Nov; 16(2):97-104. PubMed ID: 11887940
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 beta-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine.
Andersen HU; Mauricio D; Karlsen AE; Mandrup-Poulsen T; Nielsen JH; Nerup J
Eur J Endocrinol; 1996 Feb; 134(2):251-9. PubMed ID: 8630528
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1beta-induced nitric oxide production and inhibition of insulin secretion in rat islets of langerhans is dependent upon the nitric oxide synthase cofactor tetrahidrobiopterin.
Stickings P; Cunningham JM
Cytokine; 2002 Apr; 18(2):81-5. PubMed ID: 12096922
[TBL] [Abstract][Full Text] [Related]
37. Rat pancreatic islet and RINm5F cell responses to epiandrosterone, dehydroepiandrosterone and interleukin-1 beta.
Laychock SG
Biochem Pharmacol; 1998 May; 55(9):1453-64. PubMed ID: 10076538
[TBL] [Abstract][Full Text] [Related]
38. Islet protein expression changes during diabetes development in islet syngrafts in BB-DP rats and during rejection of BB-DP islet allografts.
Christensen UB; Larsen PM; Fey SJ; Andersen HU; Nawrocki A; Sparre T; Mandrup-Poulsen T; Nerup J
Autoimmunity; 2000; 32(1):1-15. PubMed ID: 10958170
[TBL] [Abstract][Full Text] [Related]
39. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide.
Corbett JA; Kwon G; Turk J; McDaniel ML
Biochemistry; 1993 Dec; 32(50):13767-70. PubMed ID: 7505613
[TBL] [Abstract][Full Text] [Related]
40. An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells.
Papaccio G; Nicoletti F; Pisanti FA; Galdieri M; Bendtzen K
Mol Med; 2002 Sep; 8(9):536-45. PubMed ID: 12456992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
